WHO expert committee on leprosy.
D001294:Attitude to Health; D001500:BCG Vaccine; D003622:Dapsone / Q000627:therapeutic use; D004185:Disability Evaluation; D004195:Disease Models, Animal; D006266:Health Education; D006801:Humans; D007916:Lepromin / Q000592:standards; D007918:Leprosy / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D008499:Medical Records; D012934:Social Isolation; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000628:therapy; D013792:Thalidomide / Q000627:therapeutic use; D014944:World Health Organization
D001500:BCG Vaccine; D013449:Sulfonamides; D013450:Sulfones; D007916:Lepromin; D013792:Thalidomide; D003622:Dapsone